Plain-English translation of NCT03609580 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
After chest surgery, many older men have trouble urinating and need a catheter placed in the bladder. This trial is testing whether Tamsulosin, a medication commonly used to help with urination, can prevent this problem when given before and after surgery. The hope is that this medication will help your bladder work normally again without needing a catheter.
Urinary retention after chest surgery affects about 1 in 4 older men and forces doctors to place a catheter, which is uncomfortable and carries risks like infection and bladder damage. This medication might offer a simpler way to prevent the problem from happening in the first place.
You likely qualify if…
You likely don't qualify if…
You would start taking the medication either 1 week or 3 days before your scheduled chest surgery and continue taking it after surgery until you can urinate normally on your own. The study compares two different start times to see which works best. You will need to monitor your bladder function closely after surgery and report any difficulty urinating to the research team.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States